Department of Hepatobiliary Surgery, The Second Hospital Affiliated to Chongqing Medical University, Chongqing, P.R. China.
BMC Infect Dis. 2024 Mar 27;24(1):355. doi: 10.1186/s12879-024-09243-x.
There are abundant studies on COVID-19 but few on its impact on hepatitis E. We aimed to assess the effect of the COVID-19 countermeasures on the pattern of hepatitis E incidence and explore the application of time series models in analyzing this pattern.
Our pivotal idea was to fit a pre-COVID-19 model with data from before the COVID-19 outbreak and use the deviation between forecast values and actual values to reflect the effect of COVID-19 countermeasures. We analyzed the pattern of hepatitis E incidence in China from 2013 to 2018. We evaluated the fitting and forecasting capability of 3 methods before the COVID-19 outbreak. Furthermore, we employed these methods to construct pre-COVID-19 incidence models and compare post-COVID-19 forecasts with reality.
Before the COVID-19 outbreak, the Chinese hepatitis E incidence pattern was overall stationary and seasonal, with a peak in March, a trough in October, and higher levels in winter and spring than in summer and autumn, annually. Nevertheless, post-COVID-19 forecasts from pre-COVID-19 models were extremely different from reality in sectional periods but congruous in others.
Since the COVID-19 pandemic, the Chinese hepatitis E incidence pattern has altered substantially, and the incidence has greatly decreased. The effect of the COVID-19 countermeasures on the pattern of hepatitis E incidence was temporary. The incidence of hepatitis E was anticipated to gradually revert to its pre-COVID-19 pattern.
有大量关于 COVID-19 的研究,但关于其对戊型肝炎影响的研究较少。我们旨在评估 COVID-19 对策对戊型肝炎发病率模式的影响,并探索时间序列模型在分析这种模式中的应用。
我们的核心思想是使用 COVID-19 爆发前的数据拟合 COVID-19 前模型,并使用预测值与实际值之间的偏差来反映 COVID-19 对策的效果。我们分析了 2013 年至 2018 年中国戊型肝炎的发病率模式。我们评估了 COVID-19 爆发前 3 种方法的拟合和预测能力。此外,我们还使用这些方法构建了 COVID-19 前的发病率模型,并将 COVID-19 后的预测与实际情况进行了比较。
在 COVID-19 爆发之前,中国戊型肝炎的发病率模式总体上是稳定的和季节性的,峰值出现在 3 月,低谷出现在 10 月,冬季和春季的水平高于夏季和秋季,每年都是如此。然而,COVID-19 前模型的 COVID-19 后预测在某些时段与实际情况非常不同,但在其他时段则一致。
自 COVID-19 大流行以来,中国戊型肝炎的发病率模式发生了重大变化,发病率大幅下降。COVID-19 对策对戊型肝炎发病率模式的影响是暂时的。预计戊型肝炎的发病率将逐渐恢复到 COVID-19 前的模式。